Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.

Li, Jing-Xin; Zhu, Feng-Cai

Li, Jing-Xin; Zhu, Feng-Cai.

Li JX; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Zhu FC; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China. Electronic address: jszfc@vip.sina.com.

Lancet ; 398(10317): 2134-2135, 2021 12 11.

Article in English | MEDLINE | ID: covidwho-1586226

Subject(s)

COVID-19; Antibodies, Neutralizing; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccines, Inactivated

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)02014-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google